Pyrazinamide (PZA) is an important antituberculosis drug. Unlike most antibacterial agents, PZA, despite its remarkable in vivo activity, has no activity against Mycobacterium tuberculosis in vitro except at an acidic pH. M. tuberculosis is uniquely susceptible to PZA, but other mycobacteria as well as nonmycobacteria are intrinsically resistant. The role of acidic pH in PZA action and the basis for the unique PZA susceptibility of M. tuberculosis are unknown. We found that in M. tuberculosis, acidic pH enhanced the intracellular accumulation of pyrazinoic acid (POA), the active derivative of PZA, after conversion of PZA by pyrazinamidase. In contrast, at neutral or alkaline pH, POA was mainly found outside M. tuberculosis cells. PZA-resistant M. tuberculosis complex organisms did not convert PZA into POA. Unlike M. tuberculosis, intrinsically PZA-resistant M. smegmatis converted PZA into POA, but it did not accumulate POA even at an acidic pH, due to a very active POA efflux mechanism. We propose that a deficient POA efflux mechanism underlies the unique susceptibility of M. tuberculosis to PZA and that the natural PZA resistance of M. smegmatis is due to a highly active efflux pump. These findings may have implications with regard to the design of new antimycobacterial drugs.
The antituberculosis drug pyrazinamide (PZA) is an analogue of nicotinamide, which is a vitamin B 3 (nicotinic acid; also called niacin) precursor. The discovery of PZA in the late 1940s as a powerful drug against tuberculosis (TB) was based on the serendipitous observation that nicotinamide, curiously, had activity against tubercle bacilli in animal models (19) . Subsequent synthesis of analogues of nicotinamide led to the identification of PZA as the most active derivative against Mycobacterium tuberculosis (12) . PZA is an important component of the current 6-month short-course TB chemotherapy. This therapy, which consists of isoniazid, rifampin, PZA, and ethambutol and is also called DOTS (for directly observed treatment, short-course), is recommended by the World Health Organization for treatment of every TB patient (30) . PZA plays a unique role in shortening the therapy from a period of 9 to 12 months down to 6 months, because PZA kills a population of semidormant tubercle bacilli, residing in an acidic environment (occurring during active inflammation), which are not killed by other TB drugs (6, 14) . Unlike other TB drugs, PZA, despite its remarkable activity in vivo (10) , has no activity against tubercle bacilli in vitro in normal culture medium (26) except under acidic-pH conditions (e.g., pH 5.5) (11) .
M. tuberculosis is uniquely susceptible to PZA, whose MIC for this bacterium is about 16 to 50 g/ml (11) . In contrast, other mycobacteria, and all nonmycobacteria, are completely insensitive to PZA (5) . In M. tuberculosis, the susceptibility to PZA correlates with the presence of a single enzyme with nicotinamidase and pyrazinamidase (PZase) activities (7) . Strains of M. tuberculosis that are resistant to PZA are often defective in PZase activity (7, 9, 28) , and we have recently cloned the M. tuberculosis PZase gene (pncA) (21) and shown that mutation of pncA is a major mechanism of PZA resistance in M. tuberculosis (22) . However, the correlation between PZase activity and PZA susceptibility does not exist for nontuberculous mycobacteria, since they have ample PZase activity but are nevertheless intrinsically resistant to PZA (5, 25) . Despite the performance of many studies, the mode of action of PZA in M. tuberculosis is unknown. Just as isoniazid requires activation by the M. tuberculosis catalase-peroxidase (32) , PZA, as a prodrug, needs to be activated by the bacterial nicotinamidasePZase into pyrazinoic acid (POA) (7, 21) , the active form of the drug, in bacterial cells. Yet, the active derivative POA is not directly used to treat TB patients, because the bactericidal activity of POA, when given orally to mice infected with M. tuberculosis, was found to be not as significant as that of the prodrug PZA, presumably due to poor absorption through the gastrointestinal tract and to significant serum binding (7) . However, the reasons why PZA requires an acidic environment to show activity and why M. tuberculosis is uniquely susceptible to PZA were unknown. In this study, we show that the role of acidic pH is to enhance the accumulation of POA and that M. tuberculosis has a defective efflux mechanism for POA whereas the naturally PZA-resistant bacterium M. smegmatis has a much more active POA efflux mechanism. In this as well as other experiments, the radioactivity associated with cells was measured by scintillation counting. The intracellular concentration of POA was calculated by assuming that 1 mg of dry cells is equivalent to 3 l of internal water (31) .
MATERIALS AND METHODS

Chemicals
TLC. For TLC, 2-l portions of radioactive supernatants or lysates were spotted onto a 0.25-mm-thick silica G gel 60 plate with an aluminum backing (Whatman). The TLC plate was developed in 1-butanol-10% ammonia (5:1). The plate was then air dried and exposed to X-ray film for autoradiography.
Determination of intracellular pH. M. tuberculosis H37Ra cells were grown in 7H9 liquid medium (pH 6.6) to late log phase. The culture was centrifuged, and the cells were resuspended in Sauton's medium (pH 5.0) at a density of 5 ϫ 10 9 /ml. POA was added to 0.4 or 4 mM (about 500 g/ml). Salicylate, used as a positive control, was also added to 4 mM. Each sample was tested in triplicate. 14 C]salicylic acid (Sigma Chemical Co.), as a pH probe, was added to a final concentration of 1 Ci/ml at time zero, 50-l portions were removed at various times and filtered through 0.45-m-pore-size nitrocellulose membranes, and the membranes were washed twice with 2 ml of 7H9 medium. Scintillation cocktail (3 ml) was then added to each filter in a counting vial, and the radioactivity was measured with a scintillation counter. The internal cell volume was measured by using 3 H 2 O and [ 14 C]taurine, and the internal pH was calculated according to the method of Rottenberg (18) .
Isolation of membrane and cytoplasmic fractions from M. tuberculosis. A late-log-phase culture of M. tuberculosis H37Ra (50 ml) was harvested, and the cells were washed twice with 40 mM potassium phosphate buffer (pH 6.5) containing 1 mM EDTA and then resuspended in 5 ml of 40 mM potassium phosphate buffer (pH 6.5) containing 0.3 mM phenylmethylsulfonyl fluoride, 1,000 U of DNase I, 0.5 mg of RNase A, and 2 mM magnesium chloride. The cell suspension (5 ml) was sonicated for 10 to 15 min on ice and then centrifuged at 13,000 rpm for 15 min to remove large cellular debris and unbroken cells. The supernatant was then spun at 32,000 rpm for 1 h to separate the membrane and cytosolic fractions. The supernatant fraction (cytosolic fraction) was saved. The pellet (membrane fraction) was washed with 40 mM potassium phosphate buffer (pH 6.5) containing 0.3 mM phenylmethylsulfonyl fluoride and 1 mM EDTA and then dissolved in 40 mM potassium phosphate buffer (pH 6.5) containing 1% Triton X-100. Both the supernatant and pellet fractions were tested for PZase activity by incubating them with [
14 C]PZA (1 to 2 Ci) in a volume of 30 l for 7 h, and the degree of conversion of [
14 C]PZA to [ 14 C]POA was monitored by TLC as described above.
PZA accumulation and conversion in PZA-susceptible and -resistant M. tuberculosis complex organisms. Two-to 3-week-old M. tuberculosis H37Ra and M. bovis BCG cultures, grown in Sauton's medium, were harvested and then washed with Sauton's medium, and the cell pellets were resuspended in Sauton's medium (pH 6.6) at 5 ϫ 10 9 cells/ml. [ 14 C]PZA was added to these cell suspensions to a concentration of 1 Ci/ml, and the cell mixtures were incubated at 37°C. At different time points, 50-l portions were removed and washed with Sauton's medium by filtration on 0.45-m-pore-size nitrocellulose filters by the use of a vacuum pump. The amount of radioactivity associated with the bacterial cells was determined by scintillation counting.
Effect of reserpine and valinomycin on accumulation of POA in M. smegmatis and M. tuberculosis. [ 14 C]PZA was added to a concentrated bacterial suspension (5 ϫ 10 9 cells/ml) in 7H9 liquid medium at pH 6.6 to a final concentration of 2 Ci/ml. A sublethal concentration of reserpine (20 M) was added to the M. smegmatis cells after they had been incubated with [
14 C]PZA for 1 min, allowing a substantial amount of PZA to be taken up by the cells and converted to POA. At various times after the addition of reserpine, 50-l portions were removed and spotted onto 0.45-m-pore-size nitrocellulose membranes under a vacuum. Because washing the M. smegmatis cells with buffer tends to remove [ 14 C]POA associated with the cells, the supernatant was removed by vacuum filtration without washing. The membrane area where the cell suspension was spotted was cut out, and the radioactivity was determined. The effect of valinomycin (1 M; sublethal concentration) was determined in the same manner, using 10 mM potassium. The effect of reserpine and valinomycin on [ 
RESULTS
Acidic pH enhances accumulation of POA in M. tuberculosis. We examined the conversion of PZA to POA and the accumulation of POA in M. tuberculosis H37Ra by incubating bacterial cells with [
14 C]PZA for 16 h under various pH conditions. Culture supernatants and bacterial lysates were analyzed by TLC followed by autoradiography (Fig. 1) . [ 14 C]PZA was converted to POA, which was not further converted into other components ( Fig. 1) . At neutral or alkaline pHs, there was little POA associated with the bacterial cells and POA was found mainly in the supernatant. In contrast, at acidic pHs, there was much more [
14 C]POA associated with the bacterial cells ( Fig. 1) , although the conversion of [ 14 C]PZA was somewhat reduced, judging from the increased amount of unaltered [ 14 C]PZA in the supernatant. This was apparently due to acid inhibition of the PZase (data not shown).
We then tested whether the increased accumulation of POA in the M. tuberculosis cells under acidic-pH conditions was due to passive distribution of POA between the bacterial cells and the medium. Using [
14 C]POA, we found that the effect of acidic pH was indeed to enhance the accumulation of POA (a weak acid with a pK a of 2.9 [3] ) in M. tuberculosis cells and that the POA accumulation was more pronounced at lower pH values (Fig. 2) . This observation is consistent with the expectation that weak acids are accumulated intracellularly under acidic-pH conditions because an equilibrium is reached when the concentration of the uncharged form or conjugate acid, which permeates through the membrane by passive diffusion, becomes equal on both sides of the membrane (16, 18) . It is noteworthy that there was a major difference in between POA accumulation at pH 6.6 and that at pH 2 to 5 ( Fig. 1 and 2 ). At pH 6.6, conditions under which PZA has no antituberculosis activity (26) , the POA concentration in the M. tuberculosis cells was similar to the external concentration; by contrast, the POA concentrations in the cells at acidic pH values, conditions under which PZA shows activity, were several-hundred-fold higher than the external concentration, as expected from the passive distribution theory ( Fig. 1 and 2) .
The internal pH. We measured the internal pH of M. tuberculosis H37Ra cells at an external pH of 5.0, using [ 5.0, the drug did not have any significant effect on the internal pH. These data suggest that the internal pH of living M. tuberculosis cells is actively maintained at close to 7.
PZA-resistant M. tuberculosis complex organisms do not accumulate PZA. Two strains, M. bovis BCG (which is naturally resistant to PZA due to a mutation at nucleotide position 169 of the pncA gene [21] ) and a PZA-resistant M. tuberculosis clinical isolate (with a nucleotide deletion at position 391 of the pncA gene) (22) , were incubated with [
14 C]PZA. Neither strain was able to convert [
14 C]PZA into POA, as demonstrated by TLC analysis (data not shown). Importantly, the intracellular concentration of PZA remained similar to the external concentration (Fig. 3 ), indicating that PZA had not accumulated. In contrast, PZA-susceptible M. tuberculosis H37Ra, with a functional PZase, was able to convert PZA and retained a significant amount of radioactivity (mostly POA in the cells, as determined by TLC) in the cells even at an external pH of 6.6 at early time points (Fig. 3) .
However, when BCG was transformed with a functional M. tuberculosis or M. avium pncA gene, the recombinant BCG strains expressed PZase activity, converted PZA to POA, accumulated POA in bacterial cells at an acidic pH, and became susceptible to PZA (data not shown). Furthermore, both BCG and the PZA-resistant M. tuberculosis isolate accumulated [ 14 C]POA from the external medium at acidic pHs (data not shown). This result is consistent with the finding that both BCG and PZA-resistant M. tuberculosis strains are still susceptible to POA (7) .
Localization of PZase in M. tuberculosis. We tested the PZase activity in the isolated membrane fraction, the cytosolic fraction, and the culture supernatant of M. tuberculosis H37Ra. The conventional PZase assay (29) was very insensitive and failed to detect PZase activity in these fractions. However, with the more sensitive method using radioactive [ 14 C]PZA, PZase activity was mainly found in the cytosolic fraction (data not shown). Similarly, most PZase activity was located in the cytosolic fraction in M. smegmatis (data not shown). No PZase activity was detected in the supernatant fluids of either M. tuberculosis or M. smegmatis cultures. These data suggest that most PZA conversion occurs in the cytoplasm.
Differences in PZA transport and conversion for PZA-susceptible M. tuberculosis and naturally resistant mycobacteria or other bacteria. The basis for the natural resistance of nontuberculous mycobacteria to some antituberculosis drugs has often been suggested to be the impermeability of their cell walls (4 (Fig. 4C) .
In similar [ 14 C]PZA conversion experiments as in Fig. 1 POA efflux in M. smegmatis and M. tuberculosis. POA is expected to be accumulated passively under acidic-pH conditions, but it did not accumulate in M. smegmatis (Fig. 5) ; we suspected that this was due to an active efflux mechanism pumping POA out of the cells. To prove this, we tested various inhibitors of energy metabolism, including CCCP (8, 27) , nigericin (17) , valinomycin (17) , and DCCD (1), as well as reserpine, a plant alkaloid that inhibits the Bacillus subtilis multidrug efflux pump (15) , by incubating M. smegmatis cells with [ 14 C]PZA at pH 6.6. Interestingly, reserpine at a sublethal concentration (20 M) allowed significant accumulation of POA in M. smegmatis cells (Fig. 6A) , although it inhibited PZA conversion to some degree because of its inhibition of PZase activity (data not shown). M. smegmatis cells extruded POA very rapidly (Fig. 6A) . Since at the internal pH of 7 only 0.01% of the POA is expected to be in the membrane-permeable uncharged form, this rapid efflux strongly suggests that M. smegmatis has an active efflux mechanism that pumps out POA, a conclusion also supported by the reserpine inhibition data. Among the energy inhibitors, valinomycin at a sublethal concentration (0.85 to 1 M) caused significant retention of [
14 C] POA in M. smegmatis cells (Fig. 6A) .
To determine whether there is an efflux mechanism for POA in M. tuberculosis, we tested the effects of reserpine and valinomycin on the accumulation of [
14 C]POA in M. tuberculosis H37Rv by adding [
14 C]PZA at pH 6.6. Reserpine caused POA accumulation in H37Rv cells (Fig. 6B) , suggesting that M. tuberculosis also has an active POA efflux mechanism. Valinomycin also caused significant retention of POA in M. tuberculosis cells (Fig. 6B) . However, the rate of POA extrusion (about 0.3 pmol/mg/min [ Fig. 6B] ) was more than 2 orders of magnitude lower than that found in M. smegmatis (about 70 pmol/ mg/min [ Fig. 6A]) . 14 C]POA (2.5 Ci/ml) was added to bacterial suspensions with a density of 5 ϫ 10 9 cells/ml at an acidic pH of 5.5, and the cells were incubated at 37°C for various lengths of time up to 7 h. Portions of the bacterial cell suspensions (50 l) were removed and washed with Sauton's medium by filtration under a vacuum. The internal POA concentrations in the bacterial cells were determined as described in Materials and Methods.
DISCUSSION
Despite the importance of PZA in shortening the length of tuberculosis therapy, its mode of action is unknown. An unusual aspect of PZA is the requirement of an acidic pH for activity against M. tuberculosis (11). However, an acidic pH alone does not directly activate PZA (11), nor does it induce the M. tuberculosis PZase and hence lead to more efficient PZA conversion to POA (23) . We have shown in this study that an acidic pH does not cause increased accumulation of PZA itself ( Fig. 1) and that it results in decreased PZA conversion to some extent through inhibition of PZase activity. Instead, we found that an acidic pH enhanced the accumulation of POA (the active derivative of PZA) in M. tuberculosis ( Fig. 1 and 2 ). This acid-facilitated accumulation of POA and the degree of POA accumulation in the cells correlate well with the previous finding that the MICs of PZA for M. tuberculosis decrease at lower pH values (20) .
The increased accumulation of POA under acidic-pH conditions could be due to active transport of POA into the cells. However, a similar accumulation of POA took place when the compound was generated inside the cytoplasm (Fig. 1) . We believe, therefore, that this is due to the passive equilibration of POA across the membrane. Any lipophilic, weak acids spontaneously diffuse through the membrane in their protonated forms and thus come to equilibrium when the concentrations of protonated forms become equal on both sides of the cytoplasmic membrane (16, 18) . Since the cytosol in living M. tuberculosis cells is maintained at a pH close to 7 (see Results), most of POA in the cytoplasm will be in the dissociated form, and the total concentration of POA here will be more than 1,000-fold higher than the concentration of protonated POA. In contrast, when the external pH is acidic-say, pH 2.9-the total concentration of POA in the external medium will be only twice that of the protonated form. At equilibrium, the concentrations of protonated POA on both sides will be equal, with the result being that the total POA concentration in the cytoplasm is several orders of magnitude higher than that in the medium at an acidic pH, precisely as observed in Fig. 2 . When the pH of the medium is close to 7, there is little difference in the pH across the membrane, and there should be no passive accumulation of POA, again as observed in this study (Fig. 2) . This hypothesis predicts that a decrease of external pH by 1 unit should increase POA accumulation by a factor of about 10. In Fig. 2 , however, the observed increase was only three-to fourfold. One possible reason for this discrepancy is the slow, active efflux of POA by M. tuberculosis cells (see below).
This concept of passive equilibration of POA explains the observation that PZA is active against M. tuberculosis only at an acidic pH, not at neutral and alkaline pH values. When M. tuberculosis cells were incubated with PZA at neutral pH, radioactive POA was found inside the cells at early time points (Fig. 3 and 6B) . This was expected, because POA was generated by the hydrolysis of PZA, a lipophilic, uncharged compound that should diffuse rapidly into the cells. Indeed, a comparison of the H37Ra data in Fig. 3 and 5 shows that PZA diffuses into cells much more rapidly than does POA. The intracellular POA thus generated then diffuses spontaneously and also by a slow, active efflux (see below) out into the medium, because there is no passive retention of POA under conditions of neutral external pH and because the volume of external medium is many orders of magnitude larger than the intracellular volume.
The finding that PZA-resistant TB complex organisms without PZase activity failed to accumulate or fix [ 14 C]PZA was somewhat unexpected. Even when closely spaced time points were used, no accumulation of PZA could be demonstrated inside the PZase-defective M. bovis BCG cells. The most plausible explanations for this observation are (i) that PZA, as a neutral amide, is not accumulated in the cell regardless of the external pH and (ii) that lipophilic, uncharged PZA passively diffuses out of the cells during the filtration washing step. In contrast, in PZase-positive, PZA-susceptible M. tuberculosis, PZA will be converted to POA as it enters the cells and POA will be trapped inside the cells due to its negative charge. Thus, the PZA uptake experiment probably does not reflect the actual PZA uptake per se but rather represents POA accumulation in the cells. In fact, there was no difference between BCG and H37Ra with regard to PZA accumulation when the bacterial cells were spun through silicone oil (data not shown). Our observation that PZA-resistant, pncA-defective M. tuberculosis complex strains did not accumulate PZA is in keeping with the previous finding that E. coli mutants defective in pncA (encoding nicotinamidase) also failed to accumulate nicotinamide (13) .
The data presented in Fig. 4 show the kinetic differences in PZA uptake, conversion to POA, and potential POA efflux among various bacteria. We believe that the differences reflect differences in PZase enzyme activity, POA efflux, and, to a much lesser extent, cell wall permeability, because PZA is a neutral amide and should passively diffuse into different cells relatively easily.
In this study, we found that the naturally PZA-resistant M. smegmatis has a highly active efflux mechanism for POA which can be inhibited by reserpine and valinomycin (Fig. 6A) . Although nigericin and CCCP did not show inhibition, this could be due to the inadequate entry of these agents through the rather impermeable cell wall or to their active efflux. The valinomycin effect thus suggests that the pump is energized by the proton motive force or one of its components. M. tuberculosis also has a POA efflux mechanism, as demonstrated by increased accumulation of POA at neutral pH in the presence of reserpine and valinomycin (Fig. 6B) . The M. tuberculosis efflux mechanism is much weaker than that of M. smegmatis, as evidenced by the orders-of-magnitude-slower kinetics of POA extrusion (compare Fig. 6B and A) . Thus, in M. tuberculosis, at an acidic external pH, the rate of passive transmembrane equilibrium of POA apparently overwhelms that of active efflux, resulting in a huge accumulation of POA in the cells. The POA efflux mechanism in M. smegmatis appears to be different from the recently identified M. smegmatis MDR pump LfrA (24) , since insertion of the lfrA gene into M. tuberculosis H37Ra did not cause enhanced efflux of POA or increased resistance to PZA or POA (unpublished data). Studies designed to identify the POA efflux mechanisms in M. smegmatis and M. tuberculosis are under way.
While both susceptible M. tuberculosis and other nonsusceptible mycobacteria have PZases to convert PZA to POA, the specificity of PZA for M. tuberculosis appears to be conferred at the stage of POA efflux, which is much weaker in M. tuberculosis than in the nonsusceptible M. smegmatis. It is noteworthy that the two types of PZA resistance, the acquired PZA resistance found in susceptible M. tuberculosis and the intrinsic PZA resistance found in nontuberculous mycobacteria, are caused by very different mechanisms. Acquired PZA resistance in susceptible M. tuberculosis is caused by mutations in the pncA gene which render the organisms unable to convert the prodrug PZA to bactericidal POA. In contrast, the intrinsic PZA resistance in M. smegmatis, and probably in many other nontuberculous mycobacteria, is due to a much more active POA efflux mechanism which does not allow accumulation of POA in the cells.
